CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Sales, net	$ 7,177,397	$ 8,295,173
Cost of sales:
Total cost of sales	8,015,805	8,297,084
Gross profit (loss)	(838,408)	(1,911)
Operating expenses:
Sales and marketing	1,734,070	1,601,808
Research and development	170,416	191,192
General and administrative	3,425,024	2,881,841
Total operating expenses	5,329,510	4,674,841
Loss from operations	(6,167,918)	(4,676,752)
Other income - TIA	1,477,730	1,482,819
Unrealized gain (loss) on debt and equity securities	192,172	(7,156,513)
Interest and other income	295,124	158,946
Interest expense	(20,441)	(23,455)
Net loss before income taxes	(4,223,333)	(10,214,955)
Provision for income taxes	1,837	285,761
Net loss	(4,225,170)	(10,500,716)
Preferred Stock dividend requirements	(57,611)	(57,611)
Net loss applicable to common shareholders	$ (4,282,781)	$ (10,558,327)
Basic loss per share	$ (0.14)	$ (0.35)
Diluted loss per share	$ (0.14)	$ (0.35)
Weighted average common shares outstanding:
Basic (in shares)	29,937,159	29,937,159
Diluted (in shares)	29,937,159	29,937,159
Cost of manufactured product
Cost of sales:
Total cost of sales	$ 7,358,809	$ 7,590,663
Royalty expense to shareholder
Cost of sales:
Total cost of sales	$ 656,996	$ 706,421